Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1989 2
1990 1
1995 2
1996 1
1998 1
1999 2
2000 1
2001 2
2003 2
2005 4
2006 2
2007 2
2008 2
2009 4
2010 4
2011 5
2012 4
2013 9
2014 10
2015 6
2016 10
2017 12
2018 16
2019 27
2020 20
2021 31
2022 41
2023 49
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors: a promising anticancer therapy.
Singh S, Hassan D, Aldawsari HM, Molugulu N, Shukla R, Kesharwani P. Singh S, et al. Among authors: hassan d. Drug Discov Today. 2020 Jan;25(1):223-229. doi: 10.1016/j.drudis.2019.11.003. Epub 2019 Nov 15. Drug Discov Today. 2020. PMID: 31738877 Review.
5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy.
Valencia-Lazcano AA, Hassan D, Pourmadadi M, Shamsabadipour A, Behzadmehr R, Rahdar A, Medina DI, Díez-Pascual AM. Valencia-Lazcano AA, et al. Among authors: hassan d. Eur J Med Chem. 2023 Jan 15;246:114995. doi: 10.1016/j.ejmech.2022.114995. Epub 2022 Dec 1. Eur J Med Chem. 2023. PMID: 36493619 Review.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939. JAMA. 2022. PMID: 35029629 Free PMC article. Clinical Trial.
257 results